Health Care Rounds

John discusses our take on health care news in the second half of October. He covers how CVS and Aetna have made a big step towards completing their merger, as well as a new proposed rule by CMS regarding transparency of pricing in drug advertisements. The U.S. Department of Justice (DOJ) has cleared the way for the $69 billion merger between CVS Health and Aetna Inc., with the stipulation that Aetna divests its Medicare Part D individual prescription drug plan business. CMS proposed a rule requiring prescription drug manufacturers to post the wholesale acquisition cost (WAC) of Medicare- and Medicaid-approved drugs in direct-to-consumer television advertising. About Darwin Research Group Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as we